Why Is Cue Biopharma ( $CUE ) Stock Down -27.4% Today? (Find out why any stock moved today on Tickeron.) CUE shares were down roughly 27.4% intraday, trading near $26.90 after closing Friday at $37.05. The slide came despite a pre-market surge sparked by positive Phase 2 data for its lead asset, CUE-221, in chronic spontaneous urticaria. The reversal reflects a classic "sell the news" dynamic after the stock's more than 300% year-to-date advance. $VCYT $AXON $AMRY $PCVX
published
Why Is Cue Biopharma ( $CUE ) Stock Down -27.4% Today? (Find out why any stock moved today on Tickeron.) CUE shares were down roughly 27.4% intraday, trading near $26.90 after closing Friday at $37.05. The slide came despite a pre-market surge sparked by posit
$CUE$VCYT$AXON$AMRY$PCVX
Latest documented BWB result
$APP market result
I Sold the $APP $310 Puts for Friday for $3 - been selling Puts on $APP every week with that hard floor of $300 and the high premium
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.